Age difference in HIV infection matters – but it’s not always the younger person who is at risk
Powerful new PrEP and treatment drug should be effective as a small weekly pill
How much 'PrEP-resistant' HIV is out there?
Study finds that women are much more vulnerable to HIV infection during pregnancy and in the months after giving birth
PrEP does not raise lipids or alter body fat, safety study finds
Long-acting injectable ARVs are convenient and private, study participants report
